Predictions
Nanorepro AG
Start price
Target price
Perf. (%)
€18.60
06.03.21
06.03.21
-
06.03.22
06.03.22
-59.84%
21.12.21
21.12.21
Could be very worthwhile Investment >20% year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.22
21.02.21
21.02.21
-
21.02.22
21.02.22
-5.21%
06.03.21
06.03.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.24
18.02.21
18.02.21
€15.00
18.02.22
18.02.22
-31.31%
19.10.21
19.10.21
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€14.52
04.02.21
04.02.21
€35.00
10.88%
21.03.21
21.03.21
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Elanix Biotechnologies AG
Start price
Target price
Perf. (%)
€0.70
10.01.21
10.01.21
€1.00
10.01.22
10.01.22
-71.22%
11.01.22
11.01.22
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.36
13.12.20
13.12.20
-
13.12.21
13.12.21
-5.96%
10.01.21
10.01.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€6.71
26.11.20
26.11.20
-
26.11.21
26.11.21
173.62%
27.11.21
27.11.21
Elanix Biotechnologies AG
Start price
Target price
Perf. (%)
€0.70
26.11.20
26.11.20
-
26.11.21
26.11.21
-70.00%
27.11.21
27.11.21
Nanorepro AG
Start price
Target price
Perf. (%)
€3.38
26.11.20
26.11.20
-
16.11.21
16.11.21
198.22%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Nanorepro AG
Start price
Target price
Perf. (%)
€3.36
16.11.20
16.11.20
-
16.11.21
16.11.21
0.60%
26.11.20
26.11.20
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
CytoTools AG
Start price
Target price
Perf. (%)
€25.00
15.11.20
15.11.20
-
15.11.21
15.11.21
-66.00%
01.11.21
01.11.21
Probably not worthwhile Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.10
14.11.20
14.11.20
-
14.11.21
14.11.21
-11.71%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Nanorepro AG
Start price
Target price
Perf. (%)
€2.94
11.11.20
11.11.20
-
11.11.21
11.11.21
14.29%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Bio-Gate AG
Start price
Target price
Perf. (%)
€5.90
04.11.20
04.11.20
-
04.11.21
04.11.21
-32.20%
05.11.21
05.11.21
Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
